Suppression of Collagen-induced Arthritis by Oral or Nasal Administration of Type II Collagen
- 1 November 1999
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 13 (3) , 315-324
- https://doi.org/10.1006/jaut.1999.0320
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitopeClinical and Experimental Immunology, 1996
- Regulation of Immune Responses of the Intestinal MucosaCritical Reviews in Immunology, 1996
- Published by American Association for the Advancement of Science (AAAS) ,1994
- Suppression of Collagen Induced Arthritis by Oral Administration of Type II Collagen: Changes in Immune and Arthritic Responses Mediated by Active Peripheral SuppressionAutoimmunity, 1993
- The role of nasopharyngeal lymphoid tissueImmunology Today, 1992
- Suppression of collagen-induced arthritis with pergastrically or intravenously administered type II collagenInflammation Research, 1986
- Immunosuppression caused by antigen feeding II. Suppressor T cells mask Peyer's patch B cell priming to orally administered antigenEuropean Journal of Immunology, 1983
- Autoimmunity to collagen in adjuvant arthritis of rats.Journal of Clinical Investigation, 1980
- Immunisation against heterologous type II collagen induces arthritis in miceNature, 1980